Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

44.40
-0.1650-0.37%
Volume:2.87M
Turnover:127.96M
Market Cap:198.22B
PE:11.09
High:44.82
Open:44.60
Low:44.34
Close:44.56
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:0.49
T/O Rate:0.09%
Dividend:1.72
Dividend Rate:3.88%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.09
PE(LYR):12.26

Loading ...

Novo Nordisk Sales Growth Could Remain Flat This Year

Dow Jones
·
Aug 25

Novo Nordisk (0QIU) Receives a Hold from Deutsche Bank

TIPRANKS
·
Aug 25

J.P. Morgan Sticks to Its Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Aug 25

Novo Nordisk’s AMAZE 9 Oral Obesity Trial: A New Pill in the Weight-Loss Race

TIPRANKS
·
Aug 25

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Aug 25

Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme

TIPRANKS
·
Aug 24

Lexicon Pharma Earns $10 Million Milestone Payment from Novo Nordisk

Dow Jones
·
Aug 24

Lexicon earns third $10M milestone payment from Novo Nordisk for LX9851

TIPRANKS
·
Aug 24

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Dow Jones
·
Aug 22

Novonesis Expects Results from Weight-Loss Drug Supplement Study in 2027

Reuters
·
Aug 20

Moderately bullish activity in Novo Nordisk with shares up 1.32%

TIPRANKS
·
Aug 20

Novo Nordisk Adds a New Early-Stage Obesity Drug to Its Pipeline

TIPRANKS
·
Aug 20

Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Aug 20

Why 2026 is Biotech's Comeback Year

Dow Jones
·
Aug 19

Movement Alert|Novo-Nordisk A/S Rises 3.02% in Regular Trading, Launches Low-Dose Oral Weight Loss Drug Clinical Trial

Market Focus
·
Aug 19

Novo Nordisk testing lower doses of oral Wegovy, Reuters reports

TIPRANKS
·
Aug 19

Novo Nordisk Starts Testing Lower-Doses of Its Wegovy Weight-Loss Pills

Dow Jones
·
Aug 19

Novo Nordisk Launches Dosage Study for Oral Semaglutide

MT Newswires Live
·
Aug 19

Novo Nordisk Tests Semaglutide’s Alzheimer’s Potential: What Investors Should Watch

TIPRANKS
·
Aug 19

BMO Capital Remains a Hold on Novo Nordisk (NVO)

TIPRANKS
·
Aug 18